 | • レポートコード：MRC2Q12-18982 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、皮膚フィラー注射のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 皮膚フィラー注射のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 皮膚フィラー注射の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 皮膚フィラー注射のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの皮膚フィラー注射の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の皮膚フィラー注射の売上および2028年までの予測に焦点を当てています。 皮膚フィラー注射のグローバル主要企業には、Luminera、Allergan、Anika Therapeutics,Inc.、LG Life Sciences、Hugel、Medytox、Merz、Sinclair Pharma、Suneva Medical、Teoxane、Bausch Health、Humedix Co、Sanofi、Galderma、Croma-Pharma GmbHなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 皮膚フィラー注射市場は、タイプとアプリケーションによって区分されます。世界の皮膚フィラー注射市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 ヒアルロン酸（HA）、カルシウムヒドロキシアパタイト（CaHA）、ポリ-L-乳酸（PLLA）、ポリメチルメタクリレート（PMMA） 【アプリケーション別セグメント】 病院、美容院、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 皮膚フィラー注射製品概要 - タイプ別市場（ヒアルロン酸（HA）、カルシウムヒドロキシアパタイト（CaHA）、ポリ-L-乳酸（PLLA）、ポリメチルメタクリレート（PMMA）） - アプリケーション別市場（病院、美容院、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の皮膚フィラー注射販売量予測2017-2028 - 世界の皮膚フィラー注射売上予測2017-2028 - 皮膚フィラー注射の地域別販売量 - 皮膚フィラー注射の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別皮膚フィラー注射販売量 - 主要メーカー別皮膚フィラー注射売上 - 主要メーカー別皮膚フィラー注射価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（ヒアルロン酸（HA）、カルシウムヒドロキシアパタイト（CaHA）、ポリ-L-乳酸（PLLA）、ポリメチルメタクリレート（PMMA）） - 皮膚フィラー注射のタイプ別販売量 - 皮膚フィラー注射のタイプ別売上 - 皮膚フィラー注射のタイプ別価格 ・アプリケーション別市場規模（病院、美容院、その他） - 皮膚フィラー注射のアプリケーション別販売量 - 皮膚フィラー注射のアプリケーション別売上 - 皮膚フィラー注射のアプリケーション別価格 ・北米市場 - 北米の皮膚フィラー注射市場規模（タイプ別、アプリケーション別） - 主要国別の皮膚フィラー注射市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの皮膚フィラー注射市場規模（タイプ別、アプリケーション別） - 主要国別の皮膚フィラー注射市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の皮膚フィラー注射市場規模（タイプ別、アプリケーション別） - 主要国別の皮膚フィラー注射市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の皮膚フィラー注射市場規模（タイプ別、アプリケーション別） - 主要国別の皮膚フィラー注射市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの皮膚フィラー注射市場規模（タイプ別、アプリケーション別） - 主要国別の皮膚フィラー注射市場規模（トルコ、サウジアラビア） ・企業情報 Luminera、Allergan、Anika Therapeutics,Inc.、LG Life Sciences、Hugel、Medytox、Merz、Sinclair Pharma、Suneva Medical、Teoxane、Bausch Health、Humedix Co、Sanofi、Galderma、Croma-Pharma GmbH ・産業チェーン及び販売チャネル分析 - 皮膚フィラー注射の産業チェーン分析 - 皮膚フィラー注射の原材料 - 皮膚フィラー注射の生産プロセス - 皮膚フィラー注射の販売及びマーケティング - 皮膚フィラー注射の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 皮膚フィラー注射の産業動向 - 皮膚フィラー注射のマーケットドライバー - 皮膚フィラー注射の課題 - 皮膚フィラー注射の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Dermal Filler Injections estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Dermal Filler Injections is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Dermal Filler Injections is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Dermal Filler Injections is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Dermal Filler Injections include Luminera, Allergan, Anika Therapeutics,Inc., LG Life Sciences, Hugel, Medytox, Merz, Sinclair Pharma and Suneva Medical, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Dermal Filler Injections companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Dermal Filler Injections market. Further, it explains the major drivers and regional dynamics of the global Dermal Filler Injections market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Luminera
Allergan
Anika Therapeutics,Inc.
LG Life Sciences
Hugel
Medytox
Merz
Sinclair Pharma
Suneva Medical
Teoxane
Bausch Health
Humedix Co
Sanofi
Galderma
Croma-Pharma GmbH
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Dermal Filler Injections Segment by Type
Hyaluronic Acid (HA)
Calcium Hydroxylapatite (CaHA)
Poly-L-Lactic Acid (PLLA)
Polymethylmethacrylate (PMMA)
Dermal Filler Injections Segment by Application
Hospital
Beauty Parlour
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Dermal Filler Injections market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Dermal Filler Injections market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Dermal Filler Injections, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Dermal Filler Injections, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Dermal Filler Injections revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Dermal Filler Injections market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Dermal Filler Injections revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Luminera, Allergan, Anika Therapeutics,Inc., LG Life Sciences, Hugel, Medytox, Merz, Sinclair Pharma and Suneva Medical, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Dermal Filler Injections in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Dermal Filler Injections companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dermal Filler Injections revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dermal Filler Injections Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Hyaluronic Acid (HA)
1.2.3 Calcium Hydroxylapatite (CaHA)
1.2.4 Poly-L-Lactic Acid (PLLA)
1.2.5 Polymethylmethacrylate (PMMA)
1.3 Market by Application
1.3.1 Global Dermal Filler Injections Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Beauty Parlour
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Dermal Filler Injections Market Perspective (2017-2028)
2.2 Dermal Filler Injections Growth Trends by Region
2.2.1 Dermal Filler Injections Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Dermal Filler Injections Historic Market Size by Region (2017-2022)
2.2.3 Dermal Filler Injections Forecasted Market Size by Region (2023-2028)
2.3 Dermal Filler Injections Market Dynamics
2.3.1 Dermal Filler Injections Industry Trends
2.3.2 Dermal Filler Injections Market Drivers
2.3.3 Dermal Filler Injections Market Challenges
2.3.4 Dermal Filler Injections Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Dermal Filler Injections Players by Revenue
3.1.1 Global Top Dermal Filler Injections Players by Revenue (2017-2022)
3.1.2 Global Dermal Filler Injections Revenue Market Share by Players (2017-2022)
3.2 Global Dermal Filler Injections Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Dermal Filler Injections Revenue
3.4 Global Dermal Filler Injections Market Concentration Ratio
3.4.1 Global Dermal Filler Injections Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dermal Filler Injections Revenue in 2021
3.5 Dermal Filler Injections Key Players Head office and Area Served
3.6 Key Players Dermal Filler Injections Product Solution and Service
3.7 Date of Enter into Dermal Filler Injections Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Dermal Filler Injections Breakdown Data by Type
4.1 Global Dermal Filler Injections Historic Market Size by Type (2017-2022)
4.2 Global Dermal Filler Injections Forecasted Market Size by Type (2023-2028)
5 Dermal Filler Injections Breakdown Data by Application
5.1 Global Dermal Filler Injections Historic Market Size by Application (2017-2022)
5.2 Global Dermal Filler Injections Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Dermal Filler Injections Market Size (2017-2028)
6.2 North America Dermal Filler Injections Market Size by Type
6.2.1 North America Dermal Filler Injections Market Size by Type (2017-2022)
6.2.2 North America Dermal Filler Injections Market Size by Type (2023-2028)
6.2.3 North America Dermal Filler Injections Market Share by Type (2017-2028)
6.3 North America Dermal Filler Injections Market Size by Application
6.3.1 North America Dermal Filler Injections Market Size by Application (2017-2022)
6.3.2 North America Dermal Filler Injections Market Size by Application (2023-2028)
6.3.3 North America Dermal Filler Injections Market Share by Application (2017-2028)
6.4 North America Dermal Filler Injections Market Size by Country
6.4.1 North America Dermal Filler Injections Market Size by Country (2017-2022)
6.4.2 North America Dermal Filler Injections Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Dermal Filler Injections Market Size (2017-2028)
7.2 Europe Dermal Filler Injections Market Size by Type
7.2.1 Europe Dermal Filler Injections Market Size by Type (2017-2022)
7.2.2 Europe Dermal Filler Injections Market Size by Type (2023-2028)
7.2.3 Europe Dermal Filler Injections Market Share by Type (2017-2028)
7.3 Europe Dermal Filler Injections Market Size by Application
7.3.1 Europe Dermal Filler Injections Market Size by Application (2017-2022)
7.3.2 Europe Dermal Filler Injections Market Size by Application (2023-2028)
7.3.3 Europe Dermal Filler Injections Market Share by Application (2017-2028)
7.4 Europe Dermal Filler Injections Market Size by Country
7.4.1 Europe Dermal Filler Injections Market Size by Country (2017-2022)
7.4.2 Europe Dermal Filler Injections Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Dermal Filler Injections Market Size (2017-2028)
8.2 Asia-Pacific Dermal Filler Injections Market Size by Type
8.2.1 Asia-Pacific Dermal Filler Injections Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Dermal Filler Injections Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Dermal Filler Injections Market Share by Type (2017-2028)
8.3 Asia-Pacific Dermal Filler Injections Market Size by Application
8.3.1 Asia-Pacific Dermal Filler Injections Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Dermal Filler Injections Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Dermal Filler Injections Market Share by Application (2017-2028)
8.4 Asia-Pacific Dermal Filler Injections Market Size by Region
8.4.1 Asia-Pacific Dermal Filler Injections Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Dermal Filler Injections Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Dermal Filler Injections Market Size (2017-2028)
9.2 Latin America Dermal Filler Injections Market Size by Type
9.2.1 Latin America Dermal Filler Injections Market Size by Type (2017-2022)
9.2.2 Latin America Dermal Filler Injections Market Size by Type (2023-2028)
9.2.3 Latin America Dermal Filler Injections Market Share by Type (2017-2028)
9.3 Latin America Dermal Filler Injections Market Size by Application
9.3.1 Latin America Dermal Filler Injections Market Size by Application (2017-2022)
9.3.2 Latin America Dermal Filler Injections Market Size by Application (2023-2028)
9.3.3 Latin America Dermal Filler Injections Market Share by Application (2017-2028)
9.4 Latin America Dermal Filler Injections Market Size by Country
9.4.1 Latin America Dermal Filler Injections Market Size by Country (2017-2022)
9.4.2 Latin America Dermal Filler Injections Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Dermal Filler Injections Market Size (2017-2028)
10.2 Middle East & Africa Dermal Filler Injections Market Size by Type
10.2.1 Middle East & Africa Dermal Filler Injections Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Dermal Filler Injections Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Dermal Filler Injections Market Share by Type (2017-2028)
10.3 Middle East & Africa Dermal Filler Injections Market Size by Application
10.3.1 Middle East & Africa Dermal Filler Injections Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Dermal Filler Injections Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Dermal Filler Injections Market Share by Application (2017-2028)
10.4 Middle East & Africa Dermal Filler Injections Market Size by Country
10.4.1 Middle East & Africa Dermal Filler Injections Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Dermal Filler Injections Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Luminera
11.1.1 Luminera Company Details
11.1.2 Luminera Business Overview
11.1.3 Luminera Dermal Filler Injections Introduction
11.1.4 Luminera Revenue in Dermal Filler Injections Business (2017-2022)
11.1.5 Luminera Recent Developments
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Allergan Business Overview
11.2.3 Allergan Dermal Filler Injections Introduction
11.2.4 Allergan Revenue in Dermal Filler Injections Business (2017-2022)
11.2.5 Allergan Recent Developments
11.3 Anika Therapeutics,Inc.
11.3.1 Anika Therapeutics,Inc. Company Details
11.3.2 Anika Therapeutics,Inc. Business Overview
11.3.3 Anika Therapeutics,Inc. Dermal Filler Injections Introduction
11.3.4 Anika Therapeutics,Inc. Revenue in Dermal Filler Injections Business (2017-2022)
11.3.5 Anika Therapeutics,Inc. Recent Developments
11.4 LG Life Sciences
11.4.1 LG Life Sciences Company Details
11.4.2 LG Life Sciences Business Overview
11.4.3 LG Life Sciences Dermal Filler Injections Introduction
11.4.4 LG Life Sciences Revenue in Dermal Filler Injections Business (2017-2022)
11.4.5 LG Life Sciences Recent Developments
11.5 Hugel
11.5.1 Hugel Company Details
11.5.2 Hugel Business Overview
11.5.3 Hugel Dermal Filler Injections Introduction
11.5.4 Hugel Revenue in Dermal Filler Injections Business (2017-2022)
11.5.5 Hugel Recent Developments
11.6 Medytox
11.6.1 Medytox Company Details
11.6.2 Medytox Business Overview
11.6.3 Medytox Dermal Filler Injections Introduction
11.6.4 Medytox Revenue in Dermal Filler Injections Business (2017-2022)
11.6.5 Medytox Recent Developments
11.7 Merz
11.7.1 Merz Company Details
11.7.2 Merz Business Overview
11.7.3 Merz Dermal Filler Injections Introduction
11.7.4 Merz Revenue in Dermal Filler Injections Business (2017-2022)
11.7.5 Merz Recent Developments
11.8 Sinclair Pharma
11.8.1 Sinclair Pharma Company Details
11.8.2 Sinclair Pharma Business Overview
11.8.3 Sinclair Pharma Dermal Filler Injections Introduction
11.8.4 Sinclair Pharma Revenue in Dermal Filler Injections Business (2017-2022)
11.8.5 Sinclair Pharma Recent Developments
11.9 Suneva Medical
11.9.1 Suneva Medical Company Details
11.9.2 Suneva Medical Business Overview
11.9.3 Suneva Medical Dermal Filler Injections Introduction
11.9.4 Suneva Medical Revenue in Dermal Filler Injections Business (2017-2022)
11.9.5 Suneva Medical Recent Developments
11.10 Teoxane
11.10.1 Teoxane Company Details
11.10.2 Teoxane Business Overview
11.10.3 Teoxane Dermal Filler Injections Introduction
11.10.4 Teoxane Revenue in Dermal Filler Injections Business (2017-2022)
11.10.5 Teoxane Recent Developments
11.11 Bausch Health
11.11.1 Bausch Health Company Details
11.11.2 Bausch Health Business Overview
11.11.3 Bausch Health Dermal Filler Injections Introduction
11.11.4 Bausch Health Revenue in Dermal Filler Injections Business (2017-2022)
11.11.5 Bausch Health Recent Developments
11.12 Humedix Co
11.12.1 Humedix Co Company Details
11.12.2 Humedix Co Business Overview
11.12.3 Humedix Co Dermal Filler Injections Introduction
11.12.4 Humedix Co Revenue in Dermal Filler Injections Business (2017-2022)
11.12.5 Humedix Co Recent Developments
11.13 Sanofi
11.13.1 Sanofi Company Details
11.13.2 Sanofi Business Overview
11.13.3 Sanofi Dermal Filler Injections Introduction
11.13.4 Sanofi Revenue in Dermal Filler Injections Business (2017-2022)
11.13.5 Sanofi Recent Developments
11.14 Galderma
11.14.1 Galderma Company Details
11.14.2 Galderma Business Overview
11.14.3 Galderma Dermal Filler Injections Introduction
11.14.4 Galderma Revenue in Dermal Filler Injections Business (2017-2022)
11.14.5 Galderma Recent Developments
11.15 Croma-Pharma GmbH
11.15.1 Croma-Pharma GmbH Company Details
11.15.2 Croma-Pharma GmbH Business Overview
11.15.3 Croma-Pharma GmbH Dermal Filler Injections Introduction
11.15.4 Croma-Pharma GmbH Revenue in Dermal Filler Injections Business (2017-2022)
11.15.5 Croma-Pharma GmbH Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer